- Home
- MBX vs HOND Comparison
MBX vs HOND Comparison
Compare MBX & HOND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBX
- HOND
- Stock Information
- Founded
- MBX 2018
- HOND 2024
- Country
- MBX United States
- HOND United States
- Employees
- MBX N/A
- HOND N/A
- Industry
- MBX
- HOND
- Sector
- MBX
- HOND
- Exchange
- MBX NYSE
- HOND NYSE
- Market Cap
- MBX 300.5M
- HOND 292.1M
- IPO Year
- MBX 2024
- HOND 2024
- Fundamental
- Price
- MBX $12.42
- HOND $11.70
- Analyst Decision
- MBX Strong Buy
- HOND
- Analyst Count
- MBX 5
- HOND 0
- Target Price
- MBX $37.40
- HOND N/A
- AVG Volume (30 Days)
- MBX 255.6K
- HOND 453.6K
- Earning Date
- MBX 05-12-2025
- HOND 01-01-0001
- Dividend Yield
- MBX N/A
- HOND N/A
- EPS Growth
- MBX N/A
- HOND N/A
- EPS
- MBX N/A
- HOND 0.20
- Revenue
- MBX N/A
- HOND N/A
- Revenue This Year
- MBX N/A
- HOND N/A
- Revenue Next Year
- MBX N/A
- HOND N/A
- P/E Ratio
- MBX N/A
- HOND $57.22
- Revenue Growth
- MBX N/A
- HOND N/A
- 52 Week Low
- MBX $4.81
- HOND $9.90
- 52 Week High
- MBX $27.50
- HOND $12.00
- Technical
- Relative Strength Index (RSI)
- MBX N/A
- HOND N/A
- Support Level
- MBX N/A
- HOND N/A
- Resistance Level
- MBX N/A
- HOND N/A
- Average True Range (ATR)
- MBX 0.00
- HOND 0.00
- MACD
- MBX 0.00
- HOND 0.00
- Stochastic Oscillator
- MBX 0.00
- HOND 0.00
About MBX MBX BIOSCIENCES INC
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.
About HOND HCM II ACQUISITION CORP
HCM II Acquisition Corp is a blank check company.